Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

560 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ramucirumab in the treatment of non-small cell lung cancer.
Arrieta O, Zatarain-Barrón ZL, Cardona AF, Carmona A, Lopez-Mejia M. Arrieta O, et al. Among authors: cardona af. Expert Opin Drug Saf. 2017 May;16(5):637-644. doi: 10.1080/14740338.2017.1313226. Epub 2017 Apr 21. Expert Opin Drug Saf. 2017. PMID: 28395526 Review.
EGFR Inhibitors Plus Bevacizumab are Superior Than EGFR Inhibitors Alone as First-Line Setting in Advanced NSCLC With EGFR Mutations and BIM Deletion Polymorphisms (BIM-CLICaP).
Cardona AF, Ordóñez-Reyes C, Ruiz-Patiño A, Garcia-Robledo JE, Barron LZ, Recondo G, Rojas L, Corrales L, Martín C, Barrón F, Sotelo C, Rodríguez J, Ricaurte L, Rolfo C, Ávila J, Mayorga D, Archila P, Otero J, Mas L, Bermudez M, Gamez T, Carranza H, Vargas C, Rosell R, Arrieta O. Cardona AF, et al. JCO Precis Oncol. 2021 Nov;5:839-848. doi: 10.1200/PO.20.00404. JCO Precis Oncol. 2021. PMID: 34994616
Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non-small cell lung cancer.
Arrieta O, Aviles-Salas A, Orozco-Morales M, Hernández-Pedro N, Cardona AF, Cabrera-Miranda L, Barrios-Bernal P, Soca-Chafre G, Cruz-Rico G, Peña-Torres ML, Moncada-Claudio G, Ramirez-Tirado LA. Arrieta O, et al. Among authors: cardona af. Cancer Med. 2020 Apr;9(7):2390-2402. doi: 10.1002/cam4.2882. Epub 2020 Feb 11. Cancer Med. 2020. PMID: 32043750 Free PMC article.
Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation.
Cardona AF, Jaramillo-Velásquez D, Ruiz-Patiño A, Polo C, Jiménez E, Hakim F, Gómez D, Ramón JF, Cifuentes H, Mejía JA, Salguero F, Ordoñez C, Muñoz Á, Bermúdez S, Useche N, Pineda D, Ricaurte L, Zatarain-Barrón ZL, Rodríguez J, Avila J, Rojas L, Jaller E, Sotelo C, Garcia-Robledo JE, Santoyo N, Rolfo C, Rosell R, Arrieta O. Cardona AF, et al. J Neurooncol. 2021 Sep;154(3):353-364. doi: 10.1007/s11060-021-03834-3. Epub 2021 Sep 9. J Neurooncol. 2021. PMID: 34498213
560 results